Literature DB >> 24862411

Vertebral artery thrombosis: a rare presentation of primary polycythaemia.

H L Gul1, S Y M Lau2, D Chan-Lam3, J-P Ng4.   

Abstract

Primary polycythaemia, also known as polycythaemia vera (PV), is a myeloproliferative neoplasm (MPN) which is associated with arterial and venous thrombosis and which can contribute to significant morbidity and mortality if untreated. Arterial thrombosis accounts for a large proportion of PV-related thrombotic events which may manifest as stroke and myocardial infarction. There is an abundance of literature documenting thrombosis arising in the cerebral vasculature secondary to PV. However, vertebral artery thrombosis associated with PV has not been previously described. We present a case of vertebral artery thrombosis as the presenting manifestation of PV. This case demonstrates the importance of recognising MPNs as a cause of an unusual presentation of thrombosis. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24862411      PMCID: PMC4039817          DOI: 10.1136/bcr-2013-201347

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  22 in total

Review 1.  Vertebrobasilar disease.

Authors:  Sean I Savitz; Louis R Caplan
Journal:  N Engl J Med       Date:  2005-06-23       Impact factor: 91.245

Review 2.  ABC of clinical haematology. Polycythaemia, primary (essential) thrombocythaemia and myelofibrosis.

Authors:  M Messinezy; T C Pearson
Journal:  BMJ       Date:  1997-02-22

Review 3.  JAK2 mutation and thrombosis in the myeloproliferative neoplasms.

Authors:  Alessandro M Vannucchi
Journal:  Curr Hematol Malig Rep       Date:  2010-01       Impact factor: 3.952

4.  How I treat polycythemia vera.

Authors:  Francesco Passamonti
Journal:  Blood       Date:  2012-05-18       Impact factor: 22.113

Review 5.  Thrombotic disease in the myeloproliferative neoplasms.

Authors:  Anna Falanga; Marina Marchetti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

6.  Age-related reduction of NO availability and oxidative stress in humans.

Authors:  S Taddei; A Virdis; L Ghiadoni; G Salvetti; G Bernini; A Magagna; A Salvetti
Journal:  Hypertension       Date:  2001-08       Impact factor: 10.190

7.  Vertebrobasilar artery occlusion.

Authors:  Jessica C Schoen; Megan M Boysen; Chase R Warren; Bharath Chakravarthy; Shahram Lotfipour
Journal:  West J Emerg Med       Date:  2011-05

8.  Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population-based study of 327 patients.

Authors:  Gilles Bonicelli; Khadija Abdulkarim; Morgane Mounier; Peter Johansson; Cédric Rossi; Valérie Jooste; Björn Andreasson; Marc Maynadié; François Girodon
Journal:  Br J Haematol       Date:  2012-11-15       Impact factor: 6.998

9.  Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome.

Authors:  Marietta Charakida; Christian Besler; Joana R Batuca; Shirish Sangle; Susanna Marques; Miguel Sousa; Guosu Wang; Dimitris Tousoulis; Jose Delgado Alves; Stavros P Loukogeorgakis; Charles Mackworth-Young; David D'Cruz; Thomas Luscher; Ulf Landmesser; John E Deanfield
Journal:  JAMA       Date:  2009-09-16       Impact factor: 56.272

10.  Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment.

Authors:  G Birgegård; L Wide
Journal:  Br J Haematol       Date:  1992-08       Impact factor: 6.998

View more
  1 in total

1.  Spinal cord infarction during physical exertion due to polycythemia vera and aortoiliac occlusive disease: A case report.

Authors:  Wei-Pin Lin; Ta-Shen Kuan; Cho-I Lin; Lin-Chieh Hsu; Yu-Ching Lin
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.